Yaniv I - Search Results

1

T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma.

Kaplinsky C, Frisch A, Cohen IJ, Goshen Y, Jaber L, Yaniv I, Stark B, Tamary H, Zaizov R. Kaplinsky C, et al. Among authors: yaniv i. Med Pediatr Oncol. 1992;20(3):229-31. doi: 10.1002/mpo.2950200310. Med Pediatr Oncol. 1992. PMID: 1574035

2

Childhood malignant thymoma: clinical, therapeutic, and immunohistochemical considerations.

Kaplinsky C, Mor C, Cohen IJ, Goshen Y, Yaniv I, Tamary H, Jaber L, Stark B, Stern S, Zaizov R. Kaplinsky C, et al. Among authors: yaniv i. Pediatr Hematol Oncol. 1992 Jul-Sep;9(3):261-8. doi: 10.3109/08880019209016594. Pediatr Hematol Oncol. 1992. PMID: 1525005

3

Deferoxamine (Desferal)-induced ocular toxicity.

Kaplinsky C, Stark B, Goshen Y, Yaniv I, Bashara S, Zaizov R. Kaplinsky C, et al. Among authors: yaniv i. Pediatr Hematol Oncol. 1988;5(4):293-7. doi: 10.3109/08880018809037369. Pediatr Hematol Oncol. 1988. PMID: 3152975

4

Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature.

Stark B, Jeison M, Shohat M, Goshen Y, Vogel R, Cohen IJ, Yaniv I, Kaplinsky C, Zaizov R. Stark B, et al. Among authors: yaniv i. Cancer Genet Cytogenet. 1994 Jul 1;75(1):11-22. doi: 10.1016/0165-4608(94)90209-7. Cancer Genet Cytogenet. 1994. PMID: 8039158 Review.

5

Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol.

Yaniv I, Fischer S, Mor C, Stark B, Goshen Y, Stein J, Cohen IJ, Zaizov R. Yaniv I, et al. Med Pediatr Oncol. 2000 Jul;35(1):8-12. doi: 10.1002/1096-911x(200007)35:1<8::aid-mpo2>3.0.co;2-p. Med Pediatr Oncol. 2000. PMID: 10881001

6

Recurrent peripheral arterial occlusion by leukemic cells sedimentation in acute promyelocytic leukemia.

Fass R, Haddad M, Zaizov R, Sandbank Y, Yaniv I, Cohen IJ, Stark B, Zelikovski A. Fass R, et al. Among authors: yaniv i. J Pediatr Surg. 1992 May;27(5):665-7. doi: 10.1016/0022-3468(92)90475-m. J Pediatr Surg. 1992. PMID: 1625146

7

Heterogeneity of childhood acute lymphoblastic leukemia (ALL): monoclonal antibodies phenotyping and induction of differentiation in vitro.

Umiel T, Luria D, Stark B, Cohen IJ, Gozes Y, Kobiler D, Kodman Y, Grunspan A, Dvir A, Yaniv I, et al. Umiel T, et al. Among authors: yaniv i. Leukemia. 1988 Dec;2(12 Suppl):88S-96S. Leukemia. 1988. PMID: 3264367

8

Genetic alterations involving chromosome 1p in children with neuroblastoma.

Avigad S, Tamir Y, Yaniv I, Goshen J, Kaplinsky C, Cohen IJ, Zaizov R. Avigad S, et al. Among authors: yaniv i. Isr J Med Sci. 1994 Aug;30(8):639-41. Isr J Med Sci. 1994. PMID: 7913920

9

Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.

Tamary H, Goshen J, Carmi D, Yaniv I, Kaplinsky C, Cohen IJ, Zaizov R. Tamary H, et al. Among authors: yaniv i. Isr J Med Sci. 1994 Aug;30(8):658-64. Isr J Med Sci. 1994. PMID: 8045754

10

Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.

Yaniv I, Saab A, Cohen IJ, Goshen Y, Loven D, Stark B, Tamary H, Zaizov R. Yaniv I, et al. J Pediatr Hematol Oncol. 1996 Feb;18(1):76-80. doi: 10.1097/00043426-199602000-00015. J Pediatr Hematol Oncol. 1996. PMID: 8556376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters